Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
Silence Therapeutics (Nasdaq: SLN), a global clinical-stage company specializing in siRNA therapies, has announced its upcoming participation in the Leerink Partners Global Healthcare Conference. The company's management will deliver a corporate overview presentation on Wednesday, March 12th at 1:00 p.m. ET.
Interested parties can access the live webcast through the Investors section of Silence's website at www.silence-therapeutics.com. A recorded version of the presentation will be made available for later viewing after the conference concludes.
Silence Therapeutics (Nasdaq: SLN), un'azienda globale in fase clinica specializzata in terapie siRNA, ha annunciato la sua prossima partecipazione alla Conferenza Globale sulla Salute di Leerink Partners. La direzione dell'azienda presenterà una panoramica aziendale mercoledì 12 marzo alle 13:00 ET.
Le parti interessate possono accedere alla diretta web attraverso la sezione Investitori del sito di Silence all'indirizzo www.silence-therapeutics.com. Una registrazione della presentazione sarà disponibile per la visione successiva al termine della conferenza.
Silence Therapeutics (Nasdaq: SLN), una empresa global en etapa clínica especializada en terapias de siRNA, ha anunciado su próxima participación en la Conferencia Global de Salud de Leerink Partners. La dirección de la empresa realizará una presentación de resumen corporativo el miércoles 12 de marzo a la 1:00 p.m. ET.
Las partes interesadas pueden acceder a la transmisión en vivo a través de la sección de Inversores del sitio web de Silence en www.silence-therapeutics.com. Una versión grabada de la presentación estará disponible para su visualización posterior al finalizar la conferencia.
Silence Therapeutics (Nasdaq: SLN)는 siRNA 치료제를 전문으로 하는 글로벌 임상 단계 회사로, Leerink Partners 글로벌 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사 경영진은 3월 12일 수요일 오후 1시 ET에 기업 개요 발표를 진행할 것입니다.
관심 있는 분들은 Silence 웹사이트의 투자자 섹션을 통해 생중계 웹캐스트에 접속할 수 있습니다. 발표의 녹화본은 컨퍼런스 종료 후 나중에 시청할 수 있도록 제공될 것입니다.
Silence Therapeutics (Nasdaq: SLN), une entreprise mondiale en phase clinique spécialisée dans les thérapies siRNA, a annoncé sa prochaine participation à la Conférence Mondiale sur la Santé de Leerink Partners. La direction de l'entreprise présentera un aperçu de l'entreprise mercredi 12 mars à 13h00 ET.
Les parties intéressées peuvent accéder à la diffusion en direct via la section Investisseurs du site web de Silence à l'adresse www.silence-therapeutics.com. Une version enregistrée de la présentation sera disponible pour visionnage ultérieur après la fin de la conférence.
Silence Therapeutics (Nasdaq: SLN), ein globales Unternehmen in der klinischen Phase, das sich auf siRNA-Therapien spezialisiert hat, hat seine bevorstehende Teilnahme an der Leerink Partners Global Healthcare Conference angekündigt. Das Management des Unternehmens wird am Mittwoch, den 12. März um 13:00 Uhr ET eine Unternehmenspräsentation halten.
Interessierte Parteien können über den Bereich Investoren auf der Website von Silence unter www.silence-therapeutics.com auf den Live-Webcast zugreifen. Eine aufgezeichnete Version der Präsentation wird nach Abschluss der Konferenz zur späteren Ansicht verfügbar sein.
- None.
- None.
The live webcast can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available following the conference.
About Silence Therapeutics
Silence Therapeutics is a global clinical-stage biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines created with proprietary siRNA (short interfering RNA) technology. Silence leverages its mRNAi GOLD™ platform to create innovative siRNAs designed to precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence focuses on areas of high unmet medical need with programs advancing in cardiovascular disease, hematology and rare diseases. For more information, please visit https://www.silence-therapeutics.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305330507/en/
Inquiries:
Silence Therapeutics plc
Gem Hopkins, VP, Head of IR and Corporate Communications
ir@silence-therapeutics.com
Tel: +1 (646) 637-3208
Source: Silence Therapeutics plc
FAQ
When is Silence Therapeutics (SLN) presenting at the Leerink Partners Healthcare Conference?
How can investors watch Silence Therapeutics' (SLN) Leerink conference presentation?
What type of therapies does Silence Therapeutics (SLN) develop?
Will Silence Therapeutics' (SLN) Leerink presentation be available for replay?
